The talent pool [in China] is growing as foreign-educated scientists and engineers are returning to their home country, initially joining the burgeoning CRO sector and MNCs,…
In Conversation
I firmly believe that the Chinese market is still a blue ocean: there is a huge amount of potential to discover and so much more value…
We want to explore a new way of doing business and having the right strategy for Gilead China is very important because all of our products…
For me, it was the best time to set up a company like Hua Medicine. The environment was ripe to leverage global innovation, China’s expertise, the…
One could say we were able to ride the wave of the recent healthcare reforms
APAC is actually the fastest-growing region for the group globally, has the highest number of employees with a headcount of over 8,000 in total, and China…
We have been pleased to witness a revolutionary regulatory reform in China in the last several years for accelerating the approval of innovative drugs,
I felt I could do more and have more impact by building and running a small, nimble and highly efficient organization to discover and develop innovative…
We want to leverage data, information and technology to transform the way medicines are developed so that they can be delivered to patients more quickly and…
China, both as a country and Chinese biotech as an industry, now has the confidence to meet global standards
My medical knowledge is limited. But I do not need to know everything. All I need to understand is the signal. If I can simulate the…
If you compare pharma industry development to a series of gold rushes, the pharma companies are the ones panning for the gold and we are the…
